Since 2018, Therapeutic Innovation Australia’s Pipeline Accelerator scheme has helped academic researchers and SMEs access the expertise and infrastructure they need to advance promising health and medical innovations.
Published in early 2025, the Pipeline Accelerator Casebook showcases how targeted support at critical early stages of therapeutic development can make a lasting impact on the path from discovery to translation.
More than just a collection of project snapshots, the casebook charts the evolution of the scheme—from its inception to then having supported over 200 research projects nationwide. It highlights the real-world impact of early-stage investment, the value of national research infrastructure, and the collaborative approach driving therapeutic innovation in Australia.
Inside the casebook:
- A retrospective on the growth and milestones of the Pipeline Accelerator scheme
- Case studies spanning small molecules, biologics, and cell and gene therapies
- Examples of how timely support helped overcome translational bottlenecks
- Reflections on what lies ahead for Australia’s therapeutic innovation ecosystem
The casebook reflects a shared commitment to turning great science into real-world health outcomes—faster, and with greater impact.
The Pipeline Accelerator scheme remains active, with two rounds of funding offered each year.
You can learn more about the application process here and see the latest outcomes here.
